Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline

Andrade, 2020, N-acetyl cysteine and catechin-derived polyphenols: a path toward multi-target compounds against Alzheimer’s disease, J. Alzheimers Dis., 75, 1219, 10.3233/JAD-200067 Ansari, 2010, Oxidative stress in the progression of Alzheimer disease in the frontal cortex, J. Neuropathol. Exp. Neurol., 69, 155, 10.1097/NEN.0b013e3181cb5af4 Avellar, 2016, The effect of D-serine administration on cognition and mood in older adults, Oncotarget, 7, 11881, 10.18632/oncotarget.7691 Bakdash, 2017, Repeated measures correlation, Front. Psychol., 8, 456, 10.3389/fpsyg.2017.00456 Baldeiras, 2008, Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease, J. Alzheimers Dis., 15, 117, 10.3233/JAD-2008-15110 Bowen, 1997, Progression to dementia in patients with isolated memory loss, Lancet, 349, 763, 10.1016/S0140-6736(96)08256-6 Cano, 2010, The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts, J. Neurol. Neurosurg. Psychiatry, 81, 1363, 10.1136/jnnp.2009.204008 Chen, 2022, Altered central and blood glutathione in Alzheimer's disease and mild cognitive impairment: a meta-analysis, Alzheimers Res. Ther., 14, 23, 10.1186/s13195-022-00961-5 Cheng, 2021, Involvement of cholinergic, adrenergic, and glutamatergic network modulation with cognitive dysfunction in Alzheimer's disease, Int. J. Mol. Sci., 22, 10.3390/ijms22052283 Chiang, 2021, Novel biomarkers of Alzheimer’s disease: based Upon N-methyl-D-aspartate receptor hypoactivation and oxidative stress, Clin. Psychopharmacol. Neurosci., 19, 423, 10.9758/cpn.2021.19.3.423 Clifton, 2019, Regulation and function of activity-dependent homer in synaptic plasticity, Mol. Neuropsychiatry, 5, 147 Creavin, 2016, Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations, Cochrane Database Syst. Rev. DeTure, 2019, The neuropathological diagnosis of Alzheimer's disease, Mol. Neurodegener., 14, 32, 10.1186/s13024-019-0333-5 Dowling, 2016, An approach for estimating item sensitivity to within-person change over time: an illustration using the Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog), Psychol. Assess., 28, 1576, 10.1037/pas0000285 Duffy, 2014, Glutathione relates to neuropsychological functioning in mild cognitive impairment, Alzheimers Dement., 10, 67, 10.1016/j.jalz.2013.01.005 Dwivedi, 2020, Glutathione in brain: overview of its conformations, functions, biochemical characteristics, quantitation and potential therapeutic role in brain disorders, Neurochem. Res., 45, 1461, 10.1007/s11064-020-03030-1 Folstein, 1975, ``Mini-mental state''. A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 Forero, 2006, Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms, J. Cell Mol. Med., 10, 796, 10.1111/j.1582-4934.2006.tb00439.x Fracassi, 2021, Oxidative damage and antioxidant response in frontal cortex of demented and nondemented individuals with Alzheimer's neuropathology, J. Neurosci., 41, 538, 10.1523/JNEUROSCI.0295-20.2020 Fukui, 1992, Molecular cloning and chromosomal localization of a human gene encoding D-amino-acid oxidase, J. Biol. Chem., 267, 18631, 10.1016/S0021-9258(19)37007-3 Gsell, 1995, Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type, J. Neurochem., 64, 1216, 10.1046/j.1471-4159.1995.64031216.x Gusti, 2021, Antioxidants-related superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione-S-transferase (GST), and nitric oxide synthase (NOS) gene variants analysis in an obese population: a preliminary case-control study, Antioxidants, 10, 595, 10.3390/antiox10040595 Guzman-Martinez, 2021, New frontiers in the prevention, diagnosis, and treatment of Alzheimer's disease, J. Alzheimers Dis., 82, S51, 10.3233/JAD-201059 Hashimoto, 2009, Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine, Biol. Psychiatry, 65, 1103, 10.1016/j.biopsych.2009.01.002 Hashimoto, 2004, Possible role of D-serine in the pathophysiology of Alzheimer's disease, Prog. Neuropsychopharmacol. Biol. Psychiatry, 28, 385, 10.1016/j.pnpbp.2003.11.009 Howley, 2017, Assessment of the target engagement and D-serine biomarker profiles of the D-amino acid oxidase inhibitors sodium benzoate and PGM030756, Neurochem. Res., 42, 3279, 10.1007/s11064-017-2367-9 Hsu, 2018, Medications used for cognitive enhancement in patients with schizophrenia, bipolar disorder, Alzheimer's disease, and Parkinson's disease, Front. Psychiatry, 9, 91, 10.3389/fpsyt.2018.00091 Ighodaro, 2018, First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid, Alex. J. Med., 54, 287 Kamat, 2016, Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer’s disease: understanding the therapeutics strategies, Mol. Neurobiol., 53, 648, 10.1007/s12035-014-9053-6 Kueper, 2018, The Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review, J. Alzheimers Dis., 63, 423, 10.3233/JAD-170991 Kumar, 2015, NMDA receptor function during senescence: implication on cognitive performance, Front. Neurosci., 9, 473, 10.3389/fnins.2015.00473 Kumar, 2013, Linking redox regulation of NMDAR synaptic function to cognitive decline during aging, J. Neurosci., 33, 15710, 10.1523/JNEUROSCI.2176-13.2013 Kurup, 2010, The role of STEP in Alzheimer's disease, Channels (Austin), 4, 347, 10.4161/chan.4.5.12910 Lane, 2023, Diagnosing Alzheimer's disease specifically and sensitively with pLG72 and cystine/glutamate antiporter SLC7A11 as blood biomarkers, Int. J. Neuropsychopharmacol., 26, 1, 10.1093/ijnp/pyac053 Lane, 2023, Endogenous antioxidants predicted outcome and increased after treatment: a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer’s disease, Psychiatry Clin. Neurosci., 77, 102, 10.1111/pcn.13504 Lane, 2021, Brain Activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial, Int. J. Neuropsychopharmacol., 24, 392, 10.1093/ijnp/pyab001 Le Douce, 2020, Impairment of Glycolysis-derived L-serine production in astrocytes contributes to cognitive deficits in Alzheimer's disease, Cell Metab., 31, 10.1016/j.cmet.2020.02.004 Lewczuk, 2020, Clinical significance of fluid biomarkers in Alzheimer's disease, Pharmacol. Rep., 72, 528, 10.1007/s43440-020-00107-0 Lin, 2014, Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial, Biol. Psychiatry, 75, 678, 10.1016/j.biopsych.2013.08.010 Lin, 2019, Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): a randomized, double-blind, placebo-controlled, 6-week trial, J. Psychopharmacol., 33, 1030, 10.1177/0269881119849815 Lin, 2021, Effect of sodium benzoate on cognitive function among patients with behavioral and psychological symptoms of dementia: secondary analysis of a randomized clinical trial, JAMA Netw. Open, 4, 10.1001/jamanetworkopen.2021.6156 Lin, 2019, The role of N-methyl-D-Aspartate receptor neurotransmission and precision medicine in behavioral and psychological symptoms of dementia, Front. Pharmacol., 10, 540, 10.3389/fphar.2019.00540 Lin, 2021, Plasma glutathione levels decreased with cognitive decline among people with mild cognitive impairment (MCI): a two-year prospective study, Antioxidants (Basel), 10 Lin, 2022, Blood D-amino acid oxidase (DAO) levels increased with cognitive decline among people with mild cognitive impairment (MCI): a two-year prospective study, Int. J. Neuropsychopharmacol., 10.1093/ijnp/pyac027 Lin, 2020, Precision medicine of sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD), Neuropsychiatr. Dis. Treat., 16, 509, 10.2147/NDT.S234371 Lin, 2017, Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging, Sci. Rep., 7, 14849, 10.1038/s41598-017-13951-7 Liss, 2021, Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis, J. Intern. Med., 290, 310, 10.1111/joim.13244 Liu, 2020, D-serine Ameliorates Motor and Cognitive Impairments in beta-amyloid 1-42 Injected Mice by Inhibiting JNK Signaling Pathway, J. Chem. Neuroanat., 109, 10.1016/j.jchemneu.2020.101852 Liu, 2021, Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD, Neurochem. Int., 144, 10.1016/j.neuint.2020.104931 Lovell, 1995, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease, Neurology, 45, 1594, 10.1212/WNL.45.8.1594 Lowe, 1990, Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer’s disease, Neuroscience, 38, 571, 10.1016/0306-4522(90)90051-5 Lu, 2009, Donepezil delays progression to AD in MCI subjects with depressive symptoms, Neurology, 72, 2115, 10.1212/WNL.0b013e3181aa52d3 Madeira, 2015, D-serine levels in Alzheimer's disease: implications for novel biomarker development, Transl. Psychiatry, 5, e561, 10.1038/tp.2015.52 Mandal, 2012, Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy, Biochem. Biophys. Res. Commun., 417, 43, 10.1016/j.bbrc.2011.11.047 Marcus, 1998, Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease, Exp. Neurol., 150, 40, 10.1006/exnr.1997.6750 Martinez de Toda, 2019, Altered redox state in whole blood cells from patients with mild cognitive impairment and Alzheimer's disease, J. Alzheimers Dis., 71, 153, 10.3233/JAD-190198 Martinez, 1993, Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia, J. Neural Transm. Park. Dis. Dement Sect., 6, 1, 10.1007/BF02252617 McKhann, 1984, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 Morris, 2014, The glutathione system: a new drug target in neuroimmune disorders, Mol. Neurobiol., 50, 1059, 10.1007/s12035-014-8705-x Morris, 1993, The clinical dementia rating (CDR): current version and scoring rules, Neurology, 43, 2412, 10.1212/WNL.43.11.2412-a Petersen, 2011, Clinical practice. Mild cognitive impairment, N. Engl. J. Med., 364, 2227, 10.1056/NEJMcp0910237 Pinheiro, 2019, Therapeutic strategies targeting amyloid-beta in Alzheimer's disease, Curr. Alzheimer Res., 16, 418, 10.2174/1567205016666190321163438 Podhorna, 2016, Alzheimer's disease assessment scale-cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies, Alzheimers Res. Ther., 8 Rosen, 1984, A new rating scale for Alzheimer's disease, Am. J. Psychiatry, 141, 1356, 10.1176/ajp.141.11.1356 Sasabe, 2012, D-amino acid oxidase controls motoneuron degeneration through D-serine, Proc. Natl. Acad. Sci. U.S.A., 109, 627, 10.1073/pnas.1114639109 Segovia, 2001, Glutamatergic neurotransmission in aging: a critical perspective, Mech. Ageing Dev., 122, 1, 10.1016/S0047-6374(00)00225-6 Snyder, 2005, Regulation of NMDA receptor trafficking by amyloid-beta, Nat. Neurosci., 8, 1051, 10.1038/nn1503 Suridjan, 2017, Lipid peroxidation markers in coronary artery disease patients with possible vascular mild cognitive impairment, J. Alzheimers Dis., 58, 885, 10.3233/JAD-161248 Tavares-Júnior, 2019, Cognitive assessment tools for screening older adults with low levels of education: a critical review, Front. Psychiatry, 10, 878, 10.3389/fpsyt.2019.00878 Weydert, 2020, Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue, Nat. Protoc., 5, 51, 10.1038/nprot.2009.197 Zabel, 2018, Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer’s disease brain: a meta-analysis in human pathological specimens, Free Radic. Biol. Med., 115, 351, 10.1016/j.freeradbiomed.2017.12.016 Zalewska, 2021, Salivary gland dysfunction and salivary redox imbalance in patients with Alzheimer's disease, Sci. Rep., 11, 23904, 10.1038/s41598-021-03456-9 Zarrouk, 2020, Association Between oxidative stress and altered cholesterol metabolism in Alzheimer's disease patients, Curr. Alzheimer Res., 17, 823, 10.2174/1567205017666201203123046